Vaccines Manufacturing: COVID-19 and Beyond

Wednesday, 9 June 2021

row-start col-md-7 #top-section top-section #about-section no-pad-bottom-section

The development of COVID-19 vaccines has provided a lifeline in the fight against the pandemic. But the evolving nature of the virus, and the huge demand for vaccines worldwide, means that increasing manufacturing capability is now a global health imperative. Vaccine manufacturing depends on complicated supply chains and research ecosystems, presenting immense challenges but also exciting opportunities.

This webinar on Vaccines Manufacturing: COVID-19 and Beyond, delivered by the UK Department for International Trade (DIT) for our valued contacts around Europe, will explore the latest research and innovations in vaccine manufacturing, not just  to address today's COVID-19 pandemic, but to prepare us for the future. 

This virtual event will bring together key actors to discuss these current and future challenges, and identify areas for collaboration. Expert speakers include representatives from the UK government's Vaccines Taskforce, MHRA (Medicines and Healthcare Products Regulatory Agency), VMIC (Vaccines Manufacturing Innovation Centre), as well as Oxford Biomedica, Valneva and other leading companies and organisations.


Date: Wednesday, 9 June

Time: 10:00 -11:45 (CEST) - 09:00 -10:45  (BST)

Please note that this event will be in English and that it will take place via Microsoft TEAMS - a link will be sent to you in advance of the event once you have registered.



Registration Deadline: 9 June 2021

row-start col-xs-15 #agenda-section
Session moderated by Jessica Griffiths - Lead for Biotech & Pharma, UK Department for International Trade (DIT), Spain. Joined by DIT Life Sciences Specialists: Jon Mowles and Zahid Latif
Wednesday, 9 June 2021
10:00 am Welcome - Ilaria Regondi -Acting HM Trade Comissioner for Europe and Harjinder Kang - Director - Healthcare, Life Sciences and Bioeconomy Sector Team, Department for International Trade
10:05 am - 10:15 amUK Government Strategy and Landscape for COVID-19 Vaccines Manufacturing - Steve Bagshaw, UK Vaccines Taskforce
10:15 am - 10:25 amMarc Dechamps, President, Council of European Bioregions (CEBR)
10:25 am - 11:00 amRoundtable 1 - R&D Opportunities in the UK Vaccines Manufacturing Ecosystem: Vaccines Manufacturing & Innovation Centre (VMIC), Medicines & Healthcare products Regulatory Agency (MHRA), Cell & Gene Therapy Catapult (CGTC), University of Oxford
11:00 am - 11:05 amInteractive Audience Polling Session
11:05 am - 11:40 amRoundtable 2 - Innovation and Future Proofing in Vaccines Manufacturing: Cobra Biologics, Valneva, Centre for Process Innovation Limited (CPI), Oxford Biomedica, Ingenza Ltd.
11:40 am - 11:45 amClosing remarks by moderator
11:45 amClose
row-start col-xs-12 #speakers-section


We have gathered together some of the most highly respected professionals in the vaccine manufacturing industry to discuss today's environment and the key questions faced by the global community.

row-end col-xs-12 top-80 no-pad-bottom-section
row-start col-xs-12 #venue-section


row-end col-sm-12 col-md-5
row-end col-sm-12 col-md-5
row-end col-xs-12 col-md-4


Register Now       back to top